- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Thrombin (Human) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Thrombin (Human)market, defines the market attractiveness level of Thrombin (Human) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Thrombin (Human) industry, describes the types of Thrombin (Human) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Thrombin (Human) market and the development prospects and opportunities of Thrombin (Human) industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Thrombin (Human) market in Chapter 13.
By Player:
Bayer
PromoCell GmbH
Grifols
BD Biosciences
Baxter
Octapharma
Life Technologies Corporation
AMRESCO Inc
Shanghai RAAS
CSL
Vitrolife AB
Sigma-Aldrich Corporation
Hualan Biological
By Type:
500IU/Vial
1000IU/Vial
2500IU/Vial
By End-User:
Biotechnology
Medicine
Microbiology
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Thrombin (Human) Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Thrombin (Human) Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Thrombin (Human) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Thrombin (Human) Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Thrombin (Human) Market Analysis and Outlook to 2022
-
7.1 Global Thrombin (Human) Consumption (2017-2022)
-
7.2 United States Thrombin (Human) Consumption (2017-2022)
-
7.3 Europe Thrombin (Human) Consumption (2017-2022)
-
7.4 China Thrombin (Human) Consumption (2017-2022)
-
7.5 Japan Thrombin (Human) Consumption (2017-2022)
-
7.6 India Thrombin (Human) Consumption (2017-2022)
-
7.7 South Korea Thrombin (Human) Consumption (2017-2022)
8 Region and Country-wise Thrombin (Human) Market Analysis and Outlook to 2028
-
8.1 Global Thrombin (Human) Consumption Forecast (2022-2028)
-
8.2 United States Thrombin (Human) Consumption Forecast (2022-2028)
-
8.3 Europe Thrombin (Human) Consumption Forecast (2022-2028)
-
8.4 China Thrombin (Human) Consumption Forecast (2022-2028)
-
8.5 Japan Thrombin (Human) Consumption Forecast (2022-2028)
-
8.6 India Thrombin (Human) Consumption Forecast (2022-2028)
-
8.7 South Korea Thrombin (Human) Consumption Forecast (2022-2028)
9 Global Thrombin (Human) Market Outlook by Types and Applications to 2022
-
9.1 Global Thrombin (Human) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 500IU/Vial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 1000IU/Vial Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 2500IU/Vial Consumption and Growth Rate (2017-2022)
-
9.2 Global Thrombin (Human) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Biotechnology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medicine Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Microbiology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Thrombin (Human) Market Outlook by Types and Applications to 2028
-
10.1 Global Thrombin (Human) Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 500IU/Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 1000IU/Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 2500IU/Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Thrombin (Human) Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Biotechnology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medicine Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Microbiology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Thrombin (Human) Import and Export Analysis (Top 5 Countries)
-
11.1 Global Thrombin (Human) Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Thrombin (Human) Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Thrombin (Human) Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Thrombin (Human) Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Thrombin (Human) Product and Service
-
14.2 PromoCell GmbH
-
14.2.1 PromoCell GmbH Company Details
-
14.2.2 PromoCell GmbH Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PromoCell GmbH Thrombin (Human) Product and Service
-
14.3 Grifols
-
14.3.1 Grifols Company Details
-
14.3.2 Grifols Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Grifols Thrombin (Human) Product and Service
-
14.4 BD Biosciences
-
14.4.1 BD Biosciences Company Details
-
14.4.2 BD Biosciences Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 BD Biosciences Thrombin (Human) Product and Service
-
14.5 Baxter
-
14.5.1 Baxter Company Details
-
14.5.2 Baxter Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Baxter Thrombin (Human) Product and Service
-
14.6 Octapharma
-
14.6.1 Octapharma Company Details
-
14.6.2 Octapharma Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Octapharma Thrombin (Human) Product and Service
-
14.7 Life Technologies Corporation
-
14.7.1 Life Technologies Corporation Company Details
-
14.7.2 Life Technologies Corporation Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Life Technologies Corporation Thrombin (Human) Product and Service
-
14.8 AMRESCO Inc
-
14.8.1 AMRESCO Inc Company Details
-
14.8.2 AMRESCO Inc Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AMRESCO Inc Thrombin (Human) Product and Service
-
14.9 Shanghai RAAS
-
14.9.1 Shanghai RAAS Company Details
-
14.9.2 Shanghai RAAS Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Shanghai RAAS Thrombin (Human) Product and Service
-
14.10 CSL
-
14.10.1 CSL Company Details
-
14.10.2 CSL Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 CSL Thrombin (Human) Product and Service
-
14.11 Vitrolife AB
-
14.11.1 Vitrolife AB Company Details
-
14.11.2 Vitrolife AB Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Vitrolife AB Thrombin (Human) Product and Service
-
14.12 Sigma-Aldrich Corporation
-
14.12.1 Sigma-Aldrich Corporation Company Details
-
14.12.2 Sigma-Aldrich Corporation Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Sigma-Aldrich Corporation Thrombin (Human) Product and Service
-
14.13 Hualan Biological
-
14.13.1 Hualan Biological Company Details
-
14.13.2 Hualan Biological Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Hualan Biological Thrombin (Human) Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Thrombin (Human)
-
Figure Thrombin (Human) Picture
-
Table Global Thrombin (Human) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Thrombin (Human) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Thrombin (Human) Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Thrombin (Human) Consumption by Country (2017-2022)
-
Figure United States Thrombin (Human) Consumption and Growth Rate (2017-2022)
-
Table Europe Thrombin (Human) Consumption and Growth Rate (2017-2022)
-
Figure China Thrombin (Human) Consumption and Growth Rate (2017-2022)
-
Figure Japan Thrombin (Human) Consumption and Growth Rate (2017-2022)
-
Figure India Thrombin (Human) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Thrombin (Human) Consumption and Growth Rate (2017-2022)
-
Figure Global Thrombin (Human) Consumption Forecast by Country (2022-2028)
-
Figure United States Thrombin (Human) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Thrombin (Human) Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Thrombin (Human) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Thrombin (Human) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Thrombin (Human) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Thrombin (Human) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 500IU/Vial Consumption and Growth Rate (2017-2022)
-
Figure Global 1000IU/Vial Consumption and Growth Rate (2017-2022)
-
Figure Global 2500IU/Vial Consumption and Growth Rate (2017-2022)
-
Figure Global Biotechnology Consumption and Growth Rate (2017-2022)
-
Figure Global Medicine Consumption and Growth Rate (2017-2022)
-
Figure Global Microbiology Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 500IU/Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 1000IU/Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 2500IU/Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotechnology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microbiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Thrombin (Human) Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Thrombin (Human) Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Thrombin (Human) Product and Service
-
Table PromoCell GmbH (Foundation Year, Company Profile and etc.)
-
Table PromoCell GmbH Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table PromoCell GmbH Thrombin (Human) Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Thrombin (Human) Product and Service
-
Table BD Biosciences (Foundation Year, Company Profile and etc.)
-
Table BD Biosciences Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table BD Biosciences Thrombin (Human) Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Thrombin (Human) Product and Service
-
Table Octapharma (Foundation Year, Company Profile and etc.)
-
Table Octapharma Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Thrombin (Human) Product and Service
-
Table Life Technologies Corporation (Foundation Year, Company Profile and etc.)
-
Table Life Technologies Corporation Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Life Technologies Corporation Thrombin (Human) Product and Service
-
Table AMRESCO Inc (Foundation Year, Company Profile and etc.)
-
Table AMRESCO Inc Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table AMRESCO Inc Thrombin (Human) Product and Service
-
Table Shanghai RAAS (Foundation Year, Company Profile and etc.)
-
Table Shanghai RAAS Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai RAAS Thrombin (Human) Product and Service
-
Table CSL (Foundation Year, Company Profile and etc.)
-
Table CSL Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Thrombin (Human) Product and Service
-
Table Vitrolife AB (Foundation Year, Company Profile and etc.)
-
Table Vitrolife AB Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vitrolife AB Thrombin (Human) Product and Service
-
Table Sigma-Aldrich Corporation (Foundation Year, Company Profile and etc.)
-
Table Sigma-Aldrich Corporation Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sigma-Aldrich Corporation Thrombin (Human) Product and Service
-
Table Hualan Biological (Foundation Year, Company Profile and etc.)
-
Table Hualan Biological Thrombin (Human) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Biological Thrombin (Human) Product and Service
-

Chinese